BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kojima M, Shimizu M, Tsuchimochi T, Koyasu M, Tanaka S, Iizuka H, Tanaka T, Okatnoto H, Tsuda F, Miyakawa Y, Mayumi M. Posttransfusion Fulminant Hepatitis B Associated with Precore-Defective HBV Mutants. Vox Sanguinis 1991;60:34-9. [DOI: 10.1111/j.1423-0410.1991.tb00868.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ohto H, Imamura S, Sato A, Kiyosawa K. Successful prevention of posttransfusion hepatitis B by the combined use of immunoglobulin, vaccine and interferon. Transfus Sci 1997;18:541-2. [PMID: 10178677 DOI: 10.1016/s0955-3886(97)00050-7] [Reference Citation Analysis]
2 Fang Z, Ling R, Wang SS, Nong J, Huang CS, Harrison TJ. HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China. J Med Virol 1998;56:18-24. [DOI: 10.1002/(sici)1096-9071(199809)56:1<18::aid-jmv4>3.0.co;2-q] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
3 Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion. 2003;43:1442-1448. [PMID: 14507277 DOI: 10.1046/j.1537-2995.2003.00512.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
4 Barbara JA. Challenges in Transfusion Microbiology. Transfusion Medicine Reviews 1993;7:96-103. [DOI: 10.1016/s0887-7963(93)70128-5] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
5 Nguyen XT, Fukuda R, Fukumoto S. Precore region mutation in hepatitis B virus genome in early stage of infection: a study in hepatitis B e antigen-positive young carriers. J Gastroenterol 1994;29:469-73. [PMID: 7951858 DOI: 10.1007/BF02361245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Sterneck M, Kalinina T, Günther S, Fischer L, Santantonio T, Greten H, Will H. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology. 1998;28:1390-1397. [PMID: 9794926 DOI: 10.1002/hep.510280530] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 1.9] [Reference Citation Analysis]
7 Schödel F, Peterson D, Hughes J, Milich D. Hepatitis B virus core particles as a vaccine carrier moiety. Int Rev Immunol 1994;11:153-65. [PMID: 7519230 DOI: 10.3109/08830189409061723] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
8 O’Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion. 2007;47:1809-1815. [PMID: 17880605 DOI: 10.1111/j.1537-2995.2007.01396.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
9 Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, Naik S. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol. 1996;25:639-643. [PMID: 8938539 DOI: 10.1016/s0168-8278(96)80232-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
10 Yotsumoto S, Kojima M, Shoji I, Yamamoto K, Okamoto H, Mishiro S. Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses. Hepatology 1992;16:31-5. [DOI: 10.1002/hep.1840160107] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 1.8] [Reference Citation Analysis]
11 García-Montalvo BM, Farfán-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med. 2005;15:371-378. [PMID: 16202051 DOI: 10.1111/j.1365-3148.2005.00610.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
12 Xu J, Brown D, Harrison T, Lin Y, Dusheiko G. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha. Hepatology. 1992;15:1002-1006. [PMID: 1592338 DOI: 10.1002/hep.1840150605] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
13 Chen H, Luo S, Lu W, Chen Z, Chen J, Zheng S, Yu J. Serum protein expression patterns in detecting a new viral protein in HBeAg-negative chronic hepatitis B. J Viral Hepat 2019;26 Suppl 1:90-7. [PMID: 31380583 DOI: 10.1111/jvh.13166] [Reference Citation Analysis]
14 Akhtar K, Sherwani RK, Sofi LA, Sharma A, Singh P. Hook's effect - a rare presentation in HBsAg screening. Indian J Hematol Blood Transfus 2009;25:27-9. [PMID: 23100968 DOI: 10.1007/s12288-009-0006-6] [Reference Citation Analysis]
15 Santantonio T, Jung M, Miska S, Pastore G, Pape GR, Will H. High prevalence and heterogeneity of HBV preC mutants in anti-HBe-positive carriers with chronic liver disease in Southern Italy. Journal of Hepatology 1991;13:S78-81. [DOI: 10.1016/0168-8278(91)90030-f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H; Japanese Red Cross NAT Screening Research Group. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007;47:1162-71. [PMID: 17581150 DOI: 10.1111/j.1537-2995.2007.01234.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
17 Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015; 7(3): 600-606 [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
18 Allain J, Reeves I, Kitchen AD, Wenham D, Williamson LM. Feasibility and usefulness of an efficient anti-HBc screening programme in blood donors. Transfus Med 1995;5:259-65. [DOI: 10.1111/j.1365-3148.1995.tb00211.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
19 Seelig R, Renz M, Seelig HP. PCR in the Diagnosis of Viral Hepatitis. Annals of Medicine 2009;24:225-30. [DOI: 10.3109/07853899209147827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 Alexopoulou A, Karayiannis P, Hadziyannis SJ, Hou J, Pickering J, Luo K, Thomas HC. Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicity. J Viral Hepat 1996;3:173-81. [DOI: 10.1111/j.1365-2893.1996.tb00092.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
21 McDonald CP. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus Med 2006;16:381-96. [PMID: 17163869 DOI: 10.1111/j.1365-3148.2006.00697.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
22 Tur-Kaspa R, Klein A, Aharonson S. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. Hepatology 1992;16:1338-42. [PMID: 1446889 DOI: 10.1002/hep.1840160606] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 2.7] [Reference Citation Analysis]
23 Lee J, Di Bisceglie AM, Baker BL, Zeldis JB. The development of a mutation in the precore region of the hepatitis B virus in a chronically infected individual. Gastroenterology 1994;106:243-7. [DOI: 10.1016/s0016-5085(94)95767-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K; the Japanese Red Cross NAT Screening Research Group. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 2005;88:10-6. [DOI: 10.1111/j.1423-0410.2005.00581.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
25 Miska S, Will H. Hepatitis B virus C-gene variants. In: Gerlich WH, editor. Research in Chronic Viral Hepatitis. Vienna: Springer; 1993. pp. 155-69. [DOI: 10.1007/978-3-7091-9312-9_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.0] [Reference Citation Analysis]
26 Barlet V, Zarski JP, Thelu MA, Bichard P, Seigneurin JM. Different prevalence of precore mutants in five members of a hepatitis-B-virus-infected family: evidence for a precore variant type in an asymptomatic anti-HBs patient. Journal of Hepatology 1994;21:797-805. [DOI: 10.1016/s0168-8278(94)80242-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Weber B, Dengler T, Berger A, Doerr HW, Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol. 2003;41:135-143. [PMID: 12517838 DOI: 10.1128/jcm.41.1.135-143.2003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
28 Busch M. Prevention of Transmission of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Infections Through Blood Transfusion by Anti-HBc Testing. Vox Sanguinis 1998;74:147-54. [DOI: 10.1111/j.1423-0410.1998.tb05413.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
29 Mowat AP. Viral infections of the liver. Liver Disorders in Childhood. Elsevier; 1994. pp. 97-137. [DOI: 10.1016/b978-0-7506-1039-1.50012-x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
30 Faure E. Alternative peptide-fusion proteins generated by out-of-frame mutations, just upstream ORFs or elongations in mutants of human hepatitis B viruses. Virus Res. 2006;117:185-201. [PMID: 16364485 DOI: 10.1016/j.virusres.2005.10.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
31 Imamura T, Yokosuka O, Kurihara T, Kanda T, Fukai K, Imazeki F, Saisho H. Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut. 2003;52:1630-1637. [PMID: 14570734 DOI: 10.1136/gut.52.11.1630] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
32 Seed CR. Value of retaining HBsAg donor screening where HBV NAT and anti-HBc donor screening apply. VOXS 2018;13:70-5. [DOI: 10.1111/voxs.12368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Aye TT, Uchida T, Becker SO, Shikata T, Mima S. Completely or nearly identical hepatitis B virus strains replicate between patients with acute or fulminant hepatitis B and their respective infectious sources. J Med Virol 1994;42:60-5. [DOI: 10.1002/jmv.1890420112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
34 Makris M, Preston F. Chronic hepatitis in haemophilia. Blood Reviews 1993;7:243-50. [DOI: 10.1016/0268-960x(93)90011-r] [Cited by in Crossref: 21] [Article Influence: 0.8] [Reference Citation Analysis]
35 Harrison TJ, Zuckerman AJ. Variants of Hepatitis B Virus. Vox Sanguinis 1992;63:161-7. [DOI: 10.1111/j.1423-0410.1992.tb05094.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
36 Hur GM, Lee YI, Suh DJ, Lee JH, Lee YI. Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implications of clustering changes in a small region of the HBV core region. J Med Virol 1996;48:38-46. [PMID: 8825708 DOI: 10.1002/(SICI)1096-9071(199601)48:1<38::AID-JMV6>3.0.CO;2-M] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
37 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
38 Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993;105:1173-8. [DOI: 10.1016/0016-5085(93)90964-e] [Cited by in Crossref: 69] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
39 Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Correlation between Anti-HBc Titers and HBV DNA in Blood Units without Detectable HBsAg. Vox Sanguinis 1992;63:107-11. [DOI: 10.1111/j.1423-0410.1992.tb02495.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 4.2] [Reference Citation Analysis]
40 Ismail N, Fish GE, Smith MB. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol. 2004;42:610-617. [PMID: 14766824 DOI: 10.1128/jcm.42.2.610-617.2004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
41 Weber B, Bayer A, Kirch P, Schlüter V, Schlieper D, Melchior W. Improved Detection of Hepatitis B Virus Surface Antigen by a New Rapid Automated Assay. J Clin Microbiol 1999;37:2639-47. [DOI: 10.1128/jcm.37.8.2639-2647.1999] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
42 Laskus T, Rakela J, Nowicki MJ, Persing DH. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995;109:1618-23. [DOI: 10.1016/0016-5085(95)90651-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 3.3] [Reference Citation Analysis]
43 Fagan EA. Acute liver failure of unknown pathogenesis: The hidden agenda. Hepatology 1994;19:1307-12. [DOI: 10.1002/hep.1840190532] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lenhoff RJ, Luscombe CA, Summers J. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus. Hepatology. 1999;29:563-571. [PMID: 9918936 DOI: 10.1002/hep.510290236] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
45 Martlew VJ, Rogan PD, Shepherd AJN, Firth SA. Hepatitis B core antibody screening of voluntary blood donors: an extended pilot study using a modified passive haemagglutination assay. Transfus Med 1993;3:229-35. [DOI: 10.1111/j.1365-3148.1993.tb00120.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
46 Corden S, Ballard AL, Ijaz S, Barbara JA, Gilbert N, Gilson RJ, Boxall EH, Tedder RS. HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol. 2003;27:52-58. [PMID: 12727529 DOI: 10.1016/s1386-6532(02)00127-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
47 Uchida T. Genetic Variations of the Hepatitis B Virus and Their Clinical Relevance. Microbiology and Immunology 1993;37:425-39. [DOI: 10.1111/j.1348-0421.1993.tb03233.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
48 Barbara JA. HEPATITIS B: OLD VIRUS, NEW PROBLEMS? Vox Sanguinis 1994;67:239-42. [DOI: 10.1111/j.1423-0410.1994.tb04584.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
49 Matsuo T, Shinzawa H, Togashi H, Aoki M, Sugahara K, Saito K, Saito T, Takahashi T, Yamaguchi I, Aoyama M, Kamada H. Highly sensitive hepatitis B surface antigen detection by measuring stable nitroxide radical formation with ESR spectroscopy. Free Radic Biol Med 1998;25:929-35. [PMID: 9840738 DOI: 10.1016/s0891-5849(98)00125-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Günther S, Fischer L, Pult I, Sterneck M, Will H. Naturally Occurring Variants of Hepatitis B Virus. Elsevier; 1999. pp. 25-137. [DOI: 10.1016/s0065-3527(08)60298-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
51 Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Miyakawa Y, Tabuchi A, Tanaka J, Yoshizawa H. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008;48:286-94. [PMID: 18028278 DOI: 10.1111/j.1537-2995.2007.01522.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 0.6] [Reference Citation Analysis]
52 Regan FA, Hewitt P, Barbara JA, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group. BMJ 2000;320:403-6. [PMID: 10669443 DOI: 10.1136/bmj.320.7232.403] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
53 Barbara JA, Garson JA. Polymerase Chain Reaction and Transfusion Microbiology. Vox Sanguinis 1993;64:73-81. [DOI: 10.1111/j.1423-0410.1993.tb02522.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
54 Sawke NG, Sawke G. Preventing Post-Transfusion Hepatitis by screening blood donors for IgM Antibody to Hepatitis B core antigen. J Glob Infect Dis 2010;2:246-7. [PMID: 20927286 DOI: 10.4103/0974-777X.68526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]